AllianceBernstein
AVBP icon

AllianceBernstein’s ArriVent BioPharma AVBP Stock Holding History

AllianceBernstein’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
43,560
+15,360
+54% +$453K ﹤0.01% 2383
2026
Q1 		$567K Hold
28,200
– – ﹤0.01% 2576
2025
Q4 		$567K Hold
28,200
– – ﹤0.01% 2598
2025
Q3 		$520K Hold
28,200
– – ﹤0.01% 2650
2025
Q2 		$614K Hold
28,200
– – ﹤0.01% 2522
2025
Q1 		$521K Hold
28,200
– – ﹤0.01% 2538
2024
Q4 		$751K Hold
28,200
– – ﹤0.01% 2464
2024
Q3 		$663K Buy
+28,200
New +$640K ﹤0.01% 2523

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein's AVBP Position: Q2 2026 in Review

AllianceBernstein increased its ArriVent BioPharma (AVBP) stake by 54% in Q2 2026, buying an estimated $453K and bringing the position to 43,560 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

AllianceBernstein first reported a position in AVBP in Q3 2024 and has held it in 8 quarters since. 158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • AllianceBernstein held 43,560 shares of ArriVent BioPharma worth $1M as of Q2 2026.
  • AllianceBernstein bought 15,360 ArriVent BioPharma shares in Q2 2026, an estimated $453K.
  • ArriVent BioPharma made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2383 holding.
  • AllianceBernstein first reported a position in ArriVent BioPharma in Q3 2024 and has held it in 8 quarters since.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.